NSE ScannerComparison · NSE · data 2026-11-01
Aarey Drugs & Pharmaceuticals Ltd. vs Accretion Pharmaceuticals Ltd.
In plain words
Size: Aarey Drugs & Pharmaceuticals Ltd. is about 1.4 times the market value of Accretion Pharmaceuticals Ltd..
Valuation (P/E): Aarey Drugs & Pharmaceuticals Ltd. 72.4 vs Accretion Pharmaceuticals Ltd. 21.9.
Return on equity: Accretion Pharmaceuticals Ltd. 27.6% vs Aarey Drugs & Pharmaceuticals Ltd. 2.7%.
Profit growth over 3 years: Accretion Pharmaceuticals Ltd. 353.1% a year vs Aarey Drugs & Pharmaceuticals Ltd. 1.7% a year.
Debt to equity: Aarey Drugs & Pharmaceuticals Ltd. 0.33 vs Accretion Pharmaceuticals Ltd. 0.23.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AAREYDRUGS | ACCPL | |
|---|---|---|
| Price | ₹106.26 | ₹190.05 |
| Market cap | ₹298 cr | ₹211 cr |
| P/E | 72.4 | 21.9 |
| P/B | — | 3.9 |
| ROE | 2.7% | 27.6% |
| ROCE | 6.0% | 38.3% |
| Debt / equity | 0.33 | 0.23 |
| Operating margin | 0.9% | 15.3% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 4.1% | 45.0% |
| Profit growth, 3 years (yearly) | 1.7% | 353.1% |
| 1-year return | 15.4% | 234.9% |
| Revenue, last 12 months | ₹415 cr | ₹90 cr |
| Net profit, last 12 months | ₹4 cr | ₹10 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹1 cr | — |
| Quarter profit vs a year earlier | -25.5% | — |
| Promoter holding | 41.45% | — |
| Health check | Weak (3.6/10) | Strong (9.1/10) |
Common questions
Which has a higher P/E, Aarey Drugs & Pharmaceuticals Ltd. or Accretion Pharmaceuticals Ltd.?
Aarey Drugs & Pharmaceuticals Ltd. trades at the higher P/E (72.4 against 21.9). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Accretion Pharmaceuticals Ltd. (27.6% against 2.7%).
Which carries more debt?
Aarey Drugs & Pharmaceuticals Ltd. has the higher debt-to-equity ratio (0.33 against 0.23).